These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37060023)

  • 41. Colon Cancer Screening - Is It Time Yet?
    Bhurgri H; Samiullah S
    J Coll Physicians Surg Pak; 2017 Jun; 27(6):327-328. PubMed ID: 28689518
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of Combined Patient Decision Aid and Patient Navigation vs Usual Care for Colorectal Cancer Screening in a Vulnerable Patient Population: A Randomized Clinical Trial.
    Reuland DS; Brenner AT; Hoffman R; McWilliams A; Rhyne RL; Getrich C; Tapp H; Weaver MA; Callan D; Cubillos L; Urquieta de Hernandez B; Pignone MP
    JAMA Intern Med; 2017 Jul; 177(7):967-974. PubMed ID: 28505217
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial.
    Green BB; Wang CY; Anderson ML; Chubak J; Meenan RT; Vernon SW; Fuller S
    Ann Intern Med; 2013 Mar; 158(5 Pt 1):301-11. PubMed ID: 23460053
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of Patient-Directed Messaging on Colorectal Cancer Screening: A Randomized Clinical Trial.
    Oyalowo A; Forde KA; Lamanna A; Kochman ML
    JAMA Netw Open; 2022 Mar; 5(3):e224529. PubMed ID: 35357457
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cross-sectional survey study of primary care clinics on evidence-based colorectal cancer screening intervention use.
    Watanabe-Galloway S; Kim J; LaCrete F; Samson K; Foster J; Farazi PA; LeVan T; Napit K
    J Rural Health; 2022 Sep; 38(4):845-854. PubMed ID: 34784067
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System.
    Mehta SJ; Jensen CD; Quinn VP; Schottinger JE; Zauber AG; Meester R; Laiyemo AO; Fedewa S; Goodman M; Fletcher RH; Levin TR; Corley DA; Doubeni CA
    J Gen Intern Med; 2016 Nov; 31(11):1323-1330. PubMed ID: 27412426
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patient Navigation Plus Tailored Digital Video Disc Increases Colorectal Cancer Screening Among Low-Income and Minority Patients Who Did Not Attend a Scheduled Screening Colonoscopy: A Randomized Trial.
    Rawl SM; Perkins SM; Tong Y; Katz ML; Carter-Bawa L; Imperiale TF; Schwartz PH; Fatima H; Krier C; Tharp K; Shedd-Steele R; Magnarella M; Malloy C; Haunert L; Gebregziabher N; Paskett ED; Champion V
    Ann Behav Med; 2024 Apr; 58(5):314-327. PubMed ID: 38470961
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Colorectal cancer screening: evidence and implementation].
    Brenner H; Hoffmeister M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Mar; 57(3):302-6. PubMed ID: 24562704
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An observational study of workflows to support fecal testing for colorectal cancer screening in primary care practices serving Medicaid enrollees.
    Mojica CM; Gunn R; Pham R; Miech EJ; Romer A; Renfro S; Clark KD; Davis MM
    BMC Cancer; 2022 Jan; 22(1):106. PubMed ID: 35078444
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy to effectiveness transition of an Educational Program to Increase Colorectal Cancer Screening (EPICS): study protocol of a cluster randomized controlled trial.
    Smith SA; Blumenthal DS
    Implement Sci; 2013 Aug; 8():86. PubMed ID: 23924263
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Implementation and First-Round Results of a Community-Based Colorectal Cancer Screening Program in Shanghai, China.
    Gong Y; Peng P; Bao P; Zhong W; Shi Y; Gu K; Zheng Y; Wu C; Cai S; Xu Y; Sheng J; Wu F
    Oncologist; 2018 Aug; 23(8):928-935. PubMed ID: 29540604
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessing the effectiveness of a community health advisor plus screen to save educational intervention on stool-based testing adherence in an African American safety net clinic population: study protocol for a randomized pragmatic trial.
    Luque JS; Matthew OO; Jackson DR; Vargas MA; Austin T; Ali A; Kiros GE; Harris CM; Tawk R; Gwede CK; Wallace K; Jean-Pierre P
    Trials; 2022 Feb; 23(1):151. PubMed ID: 35168640
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Promoting colorectal cancer screening discussion: a randomized controlled trial.
    Christy SM; Perkins SM; Tong Y; Krier C; Champion VL; Skinner CS; Springston JK; Imperiale TF; Rawl SM
    Am J Prev Med; 2013 Apr; 44(4):325-329. PubMed ID: 23498096
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The SCRIPT trial: study protocol for a randomised controlled trial of a polygenic risk score to tailor colorectal cancer screening in primary care.
    Saya S; Boyd L; Chondros P; McNamara M; King M; Milton S; Lourenco RA; Clark M; Fishman G; Marker J; Ostroff C; Allman R; Walter FM; Buchanan D; Winship I; McIntosh J; Macrae F; Jenkins M; Emery J
    Trials; 2022 Sep; 23(1):810. PubMed ID: 36163034
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluating the effects of a risk-adapted screening program for familial colorectal cancer in individuals between 25 and 50 years of age: study protocol for the prospective population-based intervention study FARKOR.
    Hoffmann S; Crispin A; Lindoerfer D; Sroczynski G; Siebert U; Mansmann U; Consortium F
    BMC Gastroenterol; 2020 May; 20(1):131. PubMed ID: 32370777
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of Interventions Intended to Increase Colorectal Cancer Screening Rates in the United States: A Systematic Review and Meta-analysis.
    Dougherty MK; Brenner AT; Crockett SD; Gupta S; Wheeler SB; Coker-Schwimmer M; Cubillos L; Malo T; Reuland DS
    JAMA Intern Med; 2018 Dec; 178(12):1645-1658. PubMed ID: 30326005
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Participation and yield of a population-based colorectal cancer screening programme in China.
    Chen H; Li N; Ren J; Feng X; Lyu Z; Wei L; Li X; Guo L; Zheng Z; Zou S; Zhang Y; Li J; Zhang K; Chen W; Dai M; He J;
    Gut; 2019 Aug; 68(8):1450-1457. PubMed ID: 30377193
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Colonoscopy vs. Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM): Rationale for Study Design.
    Dominitz JA; Robertson DJ; Ahnen DJ; Allison JE; Antonelli M; Boardman KD; Ciarleglio M; Del Curto BJ; Huang GD; Imperiale TF; Larson MF; Lieberman D; O'Connor T; O'Leary TJ; Peduzzi P; Provenzale D; Shaukat A; Sultan S; Voorhees A; Wallace R; Guarino PD
    Am J Gastroenterol; 2017 Nov; 112(11):1736-1746. PubMed ID: 29016565
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Centralized colorectal cancer screening outreach and patient navigation for vulnerable populations in North Carolina: study protocol for the SCORE randomized controlled trial.
    Malo TL; Correa SY; Moore AA; Ferrari RM; Leeman J; Brenner AT; Wheeler SB; Tan X; Reuland DS;
    Implement Sci Commun; 2021 Oct; 2(1):113. PubMed ID: 34620250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.